Bluejay Diagnostics, Inc. (NASDAQ:BJDX) Sees Significant Dec
Bluejay Diagnostics, Inc. (NASDAQ:BJDX) Sees Significant Decrease in Short Interest
Bluejay Diagnostics, Inc. (NASDAQ:BJDX – Get Rating) saw a significant drop in short interest in the month of May. As of May 31st, there was short interest totalling 117,400 shares, a drop of 40.4% from the May 15th total of 197,100 shares. Approximately 1.2% of the shares of the company are sold short. Based on […]
Related Keywords
United States, Douglas Clark Wurth, Perkins Capital Management Inc, Securities Exchange Commission, Bluejay Diagnostics Company Profile Get Rating, Nasdaq, Exchange Commission, Symphony Cartridge Library, Bluejay Diagnostics Inc, Bluejay Diagnostics, Get Rating, Director Douglas Clark Wurth, Capital Management, Diagnostics Company Profile, Symphony Fluorescence Immuno Analyzer, Nasdaq Bjdx, Bjdx, Medical, Stocks, Options, Put, Call,